In patients with a clinically isolated syndrome (CIS), the presence of oligoclonal bands (OBs) in the cerebrospinal fluid (CSF), together with its relative absence in the peripheral blood, i.e. from zero to some OBs but fewer than in the CSF, supports the diagnosis of multiple sclerosis (MS) since it provides evidence for intrathecal synthesis of immunoglobulins (Igs). This suggests that there is an inflammatory-demyelinating process primarily occurring within the central nervous system (CNS) which may be responsible for the symptoms that these patients have. 1 However, although the investigation of CSF OB is a major step forward in the MS diagnostic work-up, there are important reasons for not compulsorily including OB determination in the diagnostic algorithm of MS.
Rebuttal
In patients with a clinically isolated syndrome (CIS), the presence of oligoclonal bands (OBs) in the cerebrospinal fluid (CSF), together with its relative absence in the peripheral blood, i.e. from zero to some OBs but fewer than in the CSF, supports the diagnosis of multiple sclerosis (MS) since it provides evidence for intrathecal synthesis of immunoglobulins (Igs). This suggests that there is an inflammatory-demyelinating process primarily occurring within the central nervous system (CNS) which may be responsible for the symptoms that these patients have. 1 However, although the investigation of CSF OB is a major step forward in the MS diagnostic work-up, there are important reasons for not compulsorily including OB determination in the diagnostic algorithm of MS.
In MS, the frequency of OBs may vary between 60%, in patients who have just suffered from a CIS, 2 to more than 90%, in patients with established MS. 3 This would indicate that the absence of OBs does not necessarily mean absence of MS, and that their presence in MS patients might indicate the existence of a long-term inflammatory process within the CNS, rather than the presence or absence of such a process. This is probably the most powerful reason for not considering the OB determination in the CSF as a procedure that always has to be performed within the MS diagnostic work-up, especially in the setting of CIS when what we most need are tests with high sensitivity.
Furthermore, patients presenting with a CIS who have greater lesion loads are more likely to have OBs within the CSF than those with lower lesion loads or normal magnetic resonance imaging (MRI) scans. Interestingly, the higher the lesion volumes are at the earliest stages of the disease, the higher the probability seems to be of finding OBs in the CSF of CIS patients. 2 Thus, according to a relevant study where CSF samples of 415 consecutive patients with a CIS were analysed, the presence of CSF OBs was observed in 27% of patients who had no brain lesions in the first MRI scan, in 64% of patients with one to nine brain lesions, and in 83% of patients with 10 or more brain lesions. That would suggest, again, that in those patients having OBs in the CSF, the disease might have probably started earlier, although in a subclinical way, than in those patients without OBs or with lower lesion volumes. In fact, the presence of OBs in the CSF has been related to the presence of plasma cells in the meninges, within subarachnoid follicle-like structures, which, at the same time, are known to accumulate as time goes by and are particularly frequent in late, progressive MS. 4 This would be in agreement with the higher percentage of positive OB amongst patients with progressive MS, compared to patients with early relapseonset MS. 5 OB determination should perhaps be performed in specific situations. Recently, in a long-term study of 85 patients who experienced an acute partial transverse myelitis as a CIS, the presence of OBs after the CIS was associated with an odds ratio of 15.76 (95% confidence interval (CI), 2.95-84.24) of developing a second relapse, i.e. of conversion to clinically definite MS, after a mean follow-up period of 104.8 (29.8) months. 6 Further studies in this direction are still needed.
In primary progressive MS (PPMS), the role of OB determination may be different from other MS subtypes. Because of the characteristically lower lesion load in PPMS as compared with relapse-onset MS, the presence of additional objective data apart from an abnormal MRI scan is often required for the diagnosis of MS. In fact, it is only in the diagnostic work-up of PPMS that the presence of CSF OBs (and/or the demonstration of a raised IgG/albumin index) is still considered as one of the mainstays for the diagnosis. Nevertheless, since 2005, the demonstration of intrathecal production of immunoglobulin, although important, is no longer mandatory for the diagnosis of PPMS. 7, 8 In patients with a CIS and a normal MR the presence of OBs may identify patients at risk of converting to MS. 2 In patients who already have abnormal neuroimaging at early stages of the disease, that is, in patients whose first MRI scan shows typical MS lesions, the investigation of CSF OBs, although useful, may not add substantial information to that obtained by the MRI scan in terms of risk of conversion to CDMS or appearance of disability. More important, there is currently no evidence that allows us to incorporate the OBs naturally in a diagnostic algorithm.
Another important reason against the systematic inclusion of OB determination in the MS diagnostic algorithm is the low specificity that positive CSF OBs may have in certain circumstances. Namely, the synthesis of OBs within the CNS, although typical of MS, is not exclusive of this disease and can be found in other conditions that mimic MS, either clinically and/or radiologically. Thus, CSF OBs can be found in diseases such as demyelinating disorders of the peripheral nervous system, acute and chronic infections of the CNS, motor neuron diseases, systemic inflammatory conditions, and paraneoplastic syndromes. 1 Furthermore, the performance of a lumbar puncture requires a minimum of expertise of the physician and some special conditions of the centre where the lumbar puncture is to be performed. This means that at times this procedure cannot be carried out. Besides, since lumbar puncture may entail some -although extremely infrequent -risks, some patients may decline the performance of such a test. Therefore, if OB determination were a mandatory procedure for the diagnosis of MS, it would be very likely that a number of patients would end up having less chance of being diagnosed than other patients who, for different reasons, had undergone a lumbar puncture. We should also consider that the laboratory technique for CSF OB determination is not always optimal and may lead to wrong results. 3 In conclusion, although the determination of OBs may be useful for the diagnosis of MS, and many neurologists -including the authors of this paper -perform lumbar punctures as a matter of course, especially in patients with a CIS whose first MRI scan shows no abnormalities, there are powerful reasons against its compulsory inclusion in the MS diagnostic algorithm. Its low sensitivity at the earliest stages of the disease, its low specificity in certain circumstances, the unnecessary expense that it may represent when the MRI is already abnormal, and the absence of evidence for its natural inclusion in the MS diagnostic algorithm, are some of them.
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